Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Tanner

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2007
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trialConnie Marras, Michael P McDermott, Paula A Rochon, et al.
Military Medicine|May 17, 2024
Disability Claims for Female Veterans Exposed to Contaminated Water at Marine Base Camp LejeuneFrances M Weaver, Lishan Cao, Kevin T Stroupe, et al.
JMIR Research Protocols|June 30, 2026
Home-Based, Virtually Supervised Combined Exercise Intervention in People With Parkinson Disease: Protocol for a Randomized Controlled TrialNiyati Mehta, Miranda J Munoz, Isabel E Allen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 20, 2003
Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutationLouis C Tan, Caroline M Tanner, Rong Chen, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|September 24, 2005
Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years laterTerry Reed, Brenda L Plassman, Caroline M Tanner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2020
The Impact of COVID-19 on Access to Parkinson's Disease MedicationJulia Ling-Yu Cheong, Zhao Hang Keith Goh, Connie Marras, et al.
Movement Disorders Clinical Practice|April 18, 2023
The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's DiseaseDaniël H B Speelberg, Max J Hulshoff, Elaine Book, et al.
The Lancet. Neurology|January 31, 2020
β-adrenoreceptors and the risk of Parkinson's diseaseFranziska Hopfner, Günter U Höglinger, Gregor Kuhlenbäumer, et al.
Annals of Internal Medicine|July 20, 2005
High-dosage vitamin E supplementation and all-cause mortalityConnie Marras, Anthony E Lang, David Oakes, et al.
Neurology. Clinical Practice|April 6, 2026
Feasibility for a Community-Based Parkinson Disease Cohort in HawaiiEmma Krening, Ruby Shuman, Malika Faouzi, et al.
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2007
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trialConnie Marras, Michael P McDermott, Paula A Rochon, et al.
Military Medicine|May 17, 2024
Disability Claims for Female Veterans Exposed to Contaminated Water at Marine Base Camp LejeuneFrances M Weaver, Lishan Cao, Kevin T Stroupe, et al.
JMIR Research Protocols|June 30, 2026
Home-Based, Virtually Supervised Combined Exercise Intervention in People With Parkinson Disease: Protocol for a Randomized Controlled TrialNiyati Mehta, Miranda J Munoz, Isabel E Allen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 20, 2003
Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutationLouis C Tan, Caroline M Tanner, Rong Chen, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|September 24, 2005
Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years laterTerry Reed, Brenda L Plassman, Caroline M Tanner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 30, 2020
The Impact of COVID-19 on Access to Parkinson's Disease MedicationJulia Ling-Yu Cheong, Zhao Hang Keith Goh, Connie Marras, et al.
Movement Disorders Clinical Practice|April 18, 2023
The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's DiseaseDaniël H B Speelberg, Max J Hulshoff, Elaine Book, et al.
The Lancet. Neurology|January 31, 2020
β-adrenoreceptors and the risk of Parkinson's diseaseFranziska Hopfner, Günter U Höglinger, Gregor Kuhlenbäumer, et al.
Annals of Internal Medicine|July 20, 2005
High-dosage vitamin E supplementation and all-cause mortalityConnie Marras, Anthony E Lang, David Oakes, et al.
Neurology. Clinical Practice|April 6, 2026
Feasibility for a Community-Based Parkinson Disease Cohort in HawaiiEmma Krening, Ruby Shuman, Malika Faouzi, et al.
Pageof 21